PROTOKOL INFUZIJSKOG C VITAMINA & VITAMINA B-e-XVII
PROTOKOL INFUZIJSKOG C VITAMINA & VITAMINA B-e-XVII se može sprovoditi na sledeći način:
- Intravenozno u infuziji samostalno ili zajedno sa infuzijskim C vitaminom u obliku skorbinske kiseline
- Oralno u obliku kapsula, suvih koštica kajsije i koncentrovanog ulja iz koštica kajsije
Tu terapiju najviše sprovode američke klinike i centri u Americi i Meksiku (više od 40 klinika) iprivatne klinike za lečenje raka u Nemačkoj. Kombinuju ga sa terapijom detoksikacije, hipertermijom, ozon terapijom. Boravak na njihovim klinikama i njihove usluge lečenja su izuzetno skupe, koštaju između 21.000 eur i 40.000 eur za 30 dana. Zato su informacije kako možete tu istu tro ili šest mesečnu terapiju da sprovedete sami za manje od 2.000 eur, jako dragocene.
Nabavka intravenoznoga vitamina B-e-XVII je moguća kod proizvođača u Americi http://www.cytopharmaonline.com/en/products ili kod njihovog zastupnika u Poljskoj g. Mariusz, email: [email protected] tet: 00 48 884 33 66 55.
G. Mariusz govori slabije engleski, zato je bolje da mu pošaljete mejl. Prilikom naručivanja, treba da izvršite avansnu uplatu, paket će vam biti poslan DHL-om, a za 3 meseca terapije potrebno vam je 25 kutija infuzijskog vitamina B-e-XVII i 90 kutija intravenoznog vitamina C. Možete selektivno nabaviti ... svaki mesec (treći).
Telefon za naručivanje: 031 870 479.
- Intravenozno u obliku askorbinske kiselina. U slani infuzijski fiziološki rastvorse dodaje infuzijski C vitamin u obliku askorbinske kiselina. Pored se može dodati infuzijski vitamin B-e-XVII. A može se infuzija sa B-e-XVII sprovoditi odvojeno.
Tu terapiju / protokol zovu pacijenti "prirodna kemoterapija", jer ne oštećuje zdrave ćelije i imunski stistem. Deluje samo na rakave ćelije, na način, da se C vitamin u visokim količinama nakon ulaska kroz ćelijsku membranu rakave ćelije veže sa feritinom ili drugim teškim metalima i u hemijskoj reakciji sa njima produkuje vodonik peroksid, koji ćeliju raka ošteti do te mere da posledično odumre. C vitamin je u manlim količinama "antioksidant". A u većim količinama (između 40g do 80g u 24h) postane izuzetno jak slobodni radikal, sa namerom da ošteti ćeliju raka koja pred njim nema odbrane, niti ga može neutralizovati, kao što to učine zdrave ćelije.
- Oralno u obliku Liposomalnog C vitamina ili Natrijevoga askorbata. 1 gram Liposomalnog C vitamina je absorbilno ekvivalentan 10 grama C vitamina u obliku askorbinske kiseline
-Intravenozno (infuzijsko) sprovođenje/doziranje C vitamina moraju da sprovode stručno osposobljena medicinska lica.
Tačne informacije za sprovođenje intravenozne TERAPIJE / PROTOKOLA C VITAMINA i B-e-XVII možete dobiti kod nas u centru CanSAVE u Vrhnici (Slovenija) na individualnom terminu.
Telefon za zakazivanje termina: 00 386 (0)31 870 479.
Američki nacionalni institut za zdravlje (The National Institute of Health - NIH), Nacionalni institut za rak (National Cancer Institute - NCI) i ameri;ka agencija za hranu i lekove (Food and Drug Administration - FDA ) konačno je potvrdila zaključke istraživanja koje su sproveli dr Linus Pauling, dr Hugh Riordan i mnogi drugi naučnici i lekari u poslednjih nekoliko decenija, a koja se odnose na ulogu vitamina C kao terapeutskog sredstva u lečenju raka.
VISOK KVALITET INTRAVENSKOG VITAMINA C
Ćelije raka su za razliku od zdravih ćelija,ne samo štetne već i primitivne.
Ne samo da ne mogu koristiti kiseonik da pretvore glukozu u energiju, već one imaju i potpuni nedostatak različitih enzima koje normalne ćelije imaju u obilju. Jedan od ovih enzima je KATALAZA koji pretvara kiseonik u vodu i vodonik-peroksid, i obrnuto.
Visoke doze askorbinske kiseline (vitamin C) rezultiraju proizvodnjom peroksida u samoj ćeliji i oko ćelije. Zdrave ćelije koriste određeni metabolički potrebni vodonik peroksid i pretvaraju njegov višak u vodu i kiseonik.
Zbog činjenice da ćelije raka imaju vrlo malo katalaze, nisu u stanju da konvertuju hidrogen u vodu i kiseonik, i kao rezultat toga,ćelija ne dobija kiseionik i umire. Zbog toga je vitamin C "dobar" za zdrave ćelije i "loš" za ćelije raka.
Američki institut za zdravlje potvrđuje hipotezu koju je dr Riordan definisao u studiji "Intravenozni askorbat kao hemoterapeutski i biološki odgovor na menjajući agens":
1. Ćelije raka su više podložne efektima peroksidativnih produkata velikih doza, izazvanih askorbidom, zbog relativnog nedostatka katalaze.
2. Koncentracije askorbata dovoljno visoke za ubijanje ćelija raka mogu se postići kod ljudi.
Neil H. Riordan je prokomentarisao: "Odlično je što su naša istraživanja o vitaminu C i raku potvrdili naučnici na prestižnom Nacionalnom institutu za zdravlje.
U nastavku su navedeni brojne reference i studije o vitaminu C, u vezi sa lečenjem kancera:
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues
Qi Chen *, Michael Graham Espey, Murali C. Krishna, James B. Mitchell, Christopher P. Corpe *, Garry R. Buettner, Emily Shacter, and Mark Levine * Reference Link
*Molecular and Clinical Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; Radiation Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Free Radical and Radiation Biology Program, University of Iowa, Iowa City, IA 52242-1101; and Laboratory of Biochemistry, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892 PNAS | September 20, 2005 | vol. 102 | no. 38 | 13604-13609
Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later
By Michael J. González, Jorge R. Miranda-Massari, Edna M. Mora, Angelik Guzmán, Neil H. Riordan, Hugh D. Riordan, Joseph J. Casciari, James A. Jackson, and Angel Romá-Franco, from Integrative Cancer Therapies 4(1); 2005 pp.32-44
Intravenous Ascorbic Acid: Protocol for its Application and Use
By Hugh D. Riordan, Ronald E. Hunninghake, Neil H. Riordan, James A. Jackson, Xiao LongMeng, Paul Taylor, etal, from Puerto Rico Health Sciences Journal (2003) 22:3, 287-290
The Effect of Alternating Magnetic Field Exposure and Vitamin C on Cancer Cells
By N. Mikirova, J.A. Jackson, J.P. Casciari and H.D. Riordan, from Journal of Orthomolecular Medicine (2001) 3, 177-182
Cytotoxicity of Ascorbate, Lipoic Acid, and Other Antioxidants In Hollow Fibre In Vitro Tumours
By J.P. Casciari, N.H. Riordan, T.L. Schmidt, XL Meng, J.A. Jackson and H.D. Riordan, from British Journal of Cancer (2001) 84:11, 1544-1550
Clinical and Experimental Experiences with Intravenous Vitamin C
By N.H. Riordan, H.D. Riordan, J.A. Jackson and J.P. Casciari, from Journal of Orthomolecular Medicine (2000) 15:4, 201-213
Different Fatty Acid Composition Between Normal and Malignant Cell Lines
By X.L. Meng, N.H. Riordan, H.D. Riordan, J.A. Jackson, et al, from BioMedicina, (1999) 2:4, 5-7
Rethinking Vitamin C and Cancer: An Update on Nutritional Oncology
By M.J. Gonzalez, E. Mora, N.H. Riordan, H.D. Riordan and P. Mojica, from Cancer Prevention International (1998) 3, 215-224
Intravenous Ascorbate as a Chemotherapeutic and Biologic Response Modifying Agent
Bio-Communications Research Institute (1997)
Intravenous Vitamin C in a Terminal Cancer Patient
By N.H. Riordan, J.A. Jackson and H.D. Riordan, from Journal of Orthomolecular Medicine (1996) 11, 80-82
High-Dose Intravenous Vitamin C and Long-Time Survival of a Patient with Cancer of Head of the Pancreas
By J.A. Jackson, H.D. Riordan, R.E. Hunninghake and N.H. Riordan, from Journal of Orthomolecular Medicine (1995) 10, 87-88
Intravenous Ascorbate as a Tumor Cytotoxic Chemotherapeutic Agent
By N.H. Riordan, H.D. Riordan, X. Meng, Y. Li and J.A. Jackson, from Medical Hypotheses (1995) 44, 207-213
Case Study: High-Dose Intravenous Vitamin C in the Treatment of a Patient withAdenocarcinoma of the Kidney
By H.D. Riordan, J.A. Jackson and Mavis Schultz, from Journal of Orthomolecular Medicine (1990) 5:1, 5-7
Na donjem linku možete pogledati edukativne snimke sa predavanja na temu kako deluje terapija / protokol infuzijskog C vitamina i njegovu uspešnost:
https://www.youtube.com/watch?v=_PI_rKuQWiE&feature=youtu.be
- Izrada Liposomalnog C vitamina za oralnu upotrebu (u prevodu)
Izdelava C-vitamina je zelo enostavna, vendar za to potrebujete ustrezne pripomočke in nekaj znanja laboratorijskega dela. Pri izdelavi so pomembni faktorji:
- nakup primernih sestavin
- osnovni laboratorijski pripomočki
- natančnost in
- čistoča pri delu.
1.Ascorbat ki ga imam: 120 mg da 106,2 mg C vitamina ( navedba na embalaži) če želim 1000 mg C vit v enem gramu pripravka potrebujem 1130 mg ascorbata , pri jemanju 2x na dan za 6 dni ga potrebujem 13560 mg ali 13,56 g
2.Vsak gram naj bi imel 500 mg fosfatdiholina: Moj lecitin ima 23.000 mg FDH na 100.000 mg izdelka, torej potrebujem za en odmerek 2.174 mg lecitina , 2 odmerka 4,35 g in 6 dni 26,10 grama lecitina
Kaj torej potrebujem ?
13,56g natrijev ascorbat (17,5% - 12,5%končni)
26,1 g lecitin (33,6% - 24,6 %končni)
9,3 g alkohol ( cca 12 % za stabilizacijo in razkužitev izdelka 70% etanol,
na koncu 8,8 %)
0,2 g xantan transparent
28,5 g vode (+ 28,5 dodatno) = 57g
g.s. citronska kislina za uravnavanje Ph, brez nje je izdelek močno bazičen
V totalu bi bilo 77,7 g izdelka( brez dodatne vode), ker pa je izdelek zelo gost povečam količino vode za enkrat, to je na 57 g in je skupna količina izdelka 106,2 g
Torej če želim užiti cca 1000 mg C vitamina v enem odmerku moram užiti cca
8 g narejenega preparata ( skupna gramatura 106,2 od tega 13500 mg C vitamina)
Zakaj potrebujem toliko lecitina? Pomemben je fosfatdiholin in ker mi ne moremo nabaviti čistega fosfatdiholina (kot proizvajalci liposomskega C vitamina) temveč lecitin katerega del je ta, moramo v recepturi to upoštevati. Vsled tega pride izdelek seveda pregost če želimo enako visoko koncentracijo C vitamina kot altrient C 17,5 % in približno enako učinkovitost. Poleg tega se lecitin namaka najmanj v enaki količini vode kot je njegova teža.
Več je vode nižja je koncentracija C vitamina in kar je še bolj pomembno nižja je koncentracija Fosfatdiholina. Le ta pa je tisti ki odpira celično membrano in poskrbi da se C vit absorbira. Pri veliki količini vode boste imeli ničelno ali zelo slabo absorbcijo C vitamina, ker ne bo dovolj lecitina oz fosfatdiholina. Vse kar je na internetu ima slabo absorbcijo in skoraj nič C vitamina ter malo fosfatdiholina.
Za raztapljanje C vitamina pa potrebujemo tudi vodo poleg alkohola kot stabilizatorja in razkuževalca. Za dolgotrajno razkuževanje je potrebna koncentracija 12% 70%-tnega etanola)Naš izdelek ima na koncu manj alkohola 8,8%
Pred pripravo umij roke in razkuži vso embalažo z alkoholom. Vodo pripravi prej da bo za delo sobne temperature ( isti dan). Nabavi natančno trehtnico na 0,1 g. Rabiš mikser z več hitrostmi in palični mešalnik)
Kako narediš močan liposoimski C vitamin?
- 26,1 g lecitina preliješ z 28,5 g prečiščene ( prekuhane 10 min vre, ohladi in destiliraj čez kavni papirni filter) uporabi 250 ml embalažo In pustiš stati pokrito cca 20 do 30 minut. Nato premešaš in dobiš gel, lecitin je raztopljen.
- 9,3g alkohol + 28,5g voda +13,56g Na-ASCORBAT DOBRO RAZTOPI ( tekočina mora biti prozorna) nato dodaj 0,1-0,2 xantan transparent ( stabilizira naš gel) in dispergiraj ( torej malo premešaj),naredi se blag gel. Sedaj izmeri PH in dodaj citronsko kislino (kupiš v trgovini)toliko, da bo PH cca 6 -7 ( nevtralen) – uporabi Ph lističe in 100 ml kozarec
- Vklopi kuhinjski mikser(razkužena metlica z 70% alkoholom) na najnižjo hitrost in počasi po delih vmešaj gel v lecitin.
- Vklopi palični mešalnik, stekleno čašo postavi v hladno vodo ( tako se C vitamin ne bo pregrel )in homogeniziraj na najvišji hitrosti 1 min.
Lahko ponoviš 3x , vsakokrat zamenjaj vodo za ohlajanje lahko obložiš z ledom.
- Shrani izdelek v hladilnik.Ker vsebuje izdelek le 8,8 % alkohola in smo uporabili destilirano prekuhano in ohlajeno vodo je steriliziran ravno toliko, da ga imaš lahko vsaj teden dni.
In tako smo naredili približek liposomskena C vitamina
PS POMEMBNO : za nižanje PH ne uporabljajte sode bikarbone, saj le ta nevtralizira Na ascorbat oz. askorbinsko kislino ( reakcija kisline in baze ) in dobite natrijev karbonat, ogljikov dioksid (zato se peni ) in vodo , skratka mešanico brez C vitamina oz. aksorbinske kisline.
- Če želite še boljšo kvaliteto lahko čašo z zmesjo položite v ultrazvočni homogenizator in homogenizirate 3 krat po tri minute. Vmed zmes premešate s plastično žličko tako, da se koščki lecitina čim bolje raztopijo v zmesi. Uporaba ultrazvočnega homogenizatorja ni nujna, je pa kakovost izdelka z uporabo le tega boljša.
- raztopino lahko raztehtajte na dnevne doze ali pa pripravek shranite v hladilniku in dodajate pripravek dnevno v čaje ali hrano
Upotreba, doziranje i merenje u terapiji sa intravenoznim vitaminom C (kliknite na tekst)https://www.cansave.org/files/_upload/vitamin_c-text.pdf
INTRAVENOUS VITAMIN C and CANCER
"...it takes much more than logic and clear-cut demonstrations to overcome the inertia and dogma of established thought." — Irving Stone Irwin Stone was an early thinker and writer about vitamin C (its scientific name is ascorbic acid). He knew it would be an uphill battle to change the way the medical profession viewed vitamin C. While most doctors accept that scurvy is a vitamin C deficiency illness, few have made the rather humongous jump to seeing high dose intravenous vitamin C as a major player in the management of cancer. There is actually a wide spectrum of medical uses for vitamin C. Evidence exists documenting it as the best antiviral agent now available ... IF used at the proper dose. Vitamin C can neutralize and eliminate a wide range of toxins. Vitamin C will enhance host resistance, greatly augmenting the immune system's ability to neutralize bacterial and fungal infections. Now the National Institutes of Health has published evidence demonstrating vitamin C's anti-cancer properties. With so many medical benefits, why do so few doctors know of them? One explanation stems from ascorbic acid's designation as a "vitamin." Consider Dorland's Illustrated Medical Dictionary's definition of vitamin: A general term for a number of unrelated organic substances that occur in many foods in small amounts that are necessary in trace amounts for the normal metabolic functioning of the body. As a vitamin, only a minuscule 60 mg of ascorbic acid is needed to prevent the emergence of scurvy symptoms. As a medical treatment for cancer and life-threatening infections and toxic exposures, tens of thousands of milligrams of ascorbic acid must be administered, often by the intravenous (IV) as well as the oral route. The Center's founder, Dr. Hugh Riordan, was a true scientist who believed in the power of scientific measurement over dogma. With the establishment of The Center in 1975, he routinely checked plasma vitamin C levels in chronically ill patients. He found these sick patients to be consistently low in their plasma C levels. Interestingly enough, the cancer patients he was seeing had VERY LOW vitamin C reserves. This matched scientific literature documenting low vitamin C levels in cancer patients. Cancer cells were actively taking up vitamin C in a way that depleted tissue reserves of C. PET scans are commonly ordered by oncologists to evaluate their cancer patients for metastases (cancer spread to other organs). What is actually injected into the patient at the start of the scan is radioactive glucose. Cancer cells are anaerobic obligates, which means they depend upon glucose as their primary source of metabolic fuel. Cancer cells employ transport mechanisms called glucose transporters to actively pull in glucose. In the vast majority of animals, vitamin C is synthesized from glucose in only four metabolic steps. Hence, the molecular shape of vitamin C is remarkably similar to glucose. (Figure 1) Cancer cells will actively transport vitamin C into themselves, possibly because they mistake it for glucose. Another plausible explanation is that they are using the vitamin C as an antioxidant. Regardless, the vitamin C accumulates in cancer cells. If large amounts of vitamin C are presented to cancer cells, large amounts will be absorbed. In these unusually large concentrations, the antioxidant vitamin C will start behaving as a pro-oxidant as it interacts with intracellular copper and iron. This chemical interaction produces small amounts of hydrogen peroxide. Because cancer cells are relatively low in an intracellular anti-oxidant enzyme called catalase, the high dose vitamin C induction of peroxide will continue to build up until it eventually lyses the cancer cell from the inside out! This effectively makes high dose IVC a non-toxic chemotherapeutic agent that can be given in conjunction with conventional cancer treatments. Based on the work of several vitamin C pioneers before him, Dr. Riordan was able to prove that vitamin C was selectively toxic to cancer cells if given intravenously. This research was recently reproduced and published by Dr. Mark Levine at the National Institutes of Health. As feared by many oncologists, small doses may actually help the cancer cells because small amounts of vitamin C may help the cancer cells arm themselves against the free-radical induced damage caused by chemotherapy and radiation. Only markedly higher doses of vitamin C will selectively build up as peroxide in the cancer cells to the point of acting in a manner similar to chemotherapy. These tumor-toxic dosages can only be obtained by intravenous administration. Over a span of 15 years of vitamin C research, Dr. Riordan's RECNAC (cancer spelled backwards) research team generated 20 published papers on vitamin C and cancer. RECNAC even inspired its second cancer research institute, known as RECNAC II, at the University of Puerto Rico. This group recently published an excellent paper in Integrative Cancer Therapies, titled "Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later." RECNAC data has shown that vitamin C is toxic to tumor cells without sacrificing the performance of chemotherapy. Intravenous vitamin C also does more than just kill cancer cells. It boosts immunity. It can stimulate collagen formation to help the body wall off the tumor. It inhibits hyaluronidase, an enzyme that tumors use to metastasize and invade other organs throughout the body. It induces apoptosis to help program cancer cells into dying early. It corrects the almost universal scurvy in cancer patients. Cancer patients are tired, listless, bruise easily, and have a poor appetite. They don't sleep well and have a low threshold for pain. This adds up to a very classic picture of scurvy that generally goes unrecognized by their conventional physicians. When Center cancer patients receive IVC, they report that their pain level goes down, and that they are better able to tolerate their chemotherapy. They bounce back quicker since the IVC reduces the toxicity of the chemotherapy and radiation without compromising their cancer cell killing effects. IVC is complementary to oncologic care. IVC is not "either/or" - it's a good "both/and" proposition. IVC can help cancer patients withstand the effects of their traditional therapies, heal faster, be more resilient to infection, develop a better appetite, and remain more active overall. These things promote a better response to their cancer therapy. IVC has been used for three decades here at The Center. There have been no serious complications, but there are a couple of potential complications that need to be screened for. Because vitamin C enhances iron absorption, iron overload must be ruled out. The high sodium load of IVC can create a fluid overload in a patient with congestive heart failure, renal insufficiency or failure. We also check our patients for G6PD deficiency (an enzyme used to maintain stability of the red blood cell membranes). Although many physicians worry that large doses of vitamin C may cause kidney stones, we have rarely seen the phenomenon, and several huge clinical trials in the medical literature refute this misconception. To summarize, most organisms make their own vitamin C. When they are under stress, either by illness or injury, Mother Nature has provided them with a means to facilitate healing: they synthesize more ascorbic acid. As a result, they are in less pain, they remain active, they can sleep, and they have a better appetite: all functions which promote healing. Dr. Riordan once said that here at The Center, we don't treat cancer... we treat people who happen to have cancer. IVC is a tool that allows our Center physicians to harness a healing mechanism that our human ancestors lost long ago: the ability to dramatically increase tissue levels of vitamin C. Research shows that the astonishingly high levels achievable only by IVC not only help fight the risk of infection and the pain of metastases, they actually aid in the defeat of the cancer cells themselves, through a very elegant mechanism that does no harm to healthy cells. It's a discovery that the medical world is only beginning to discover. Ron Hunninghake, M.D., |
